Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00639301 · ClinicalTrials.gov registry record
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life
A clinical trial of Retinoblastoma, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 473
- Enrollment target
- 1
- Study location
NCT00639301: Active study of Retinoblastoma, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00639301 is a study of Retinoblastoma that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 473 participants, below the 561-participant average among 15 other Retinoblastoma trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00639301, a study of Retinoblastoma, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 473 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out about the quality of life and health in a group of adults who had retinoblastoma when they were children. By quality of life, we mean how you are feeling about being satisfied with things in your life, including your physical health, your emotional health, and your ability to carry out daily activities. We hope that this information will help us provide better care to future children with retinoblastoma and better follow-up care for survivors of retinoblastoma.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 473 participants |
| Start Date | 2008-03-11 |
| Est. Completion | 2027-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00639301
The ClinicalTrials.gov registry entry for NCT00639301 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 473 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 561-participant average among 15 other Retinoblastoma trials with a reported enrollment target (16% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Retinoblastoma appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.
NCT00639301 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00639301 about?
NCT00639301 is a clinical study titled "Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life". The purpose of this study is to find out about the quality of life and health in a group of adults who had retinoblastoma when they were children. By quality of life, we mean how you are feeling about being satisfied with things in your life, including your physical health, your emotional health, an...
What is the current status of trial NCT00639301?
This trial is currently active not recruiting. The enrollment target is 473 participants. The study started on 2008-03-11. Estimated completion is 2027-03.
What conditions does trial NCT00639301 study?
This clinical trial studies the following conditions: Retinoblastoma.
What interventions are being tested in trial NCT00639301?
The interventions under investigation include: Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00639301?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00639301 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinoblastoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
RB Liquid Biopsy Biorepository
RECRUITING
-
GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma
RECRUITING · Phase 1
-
Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
RECRUITING
-
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
RECRUITING
-
Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients
RECRUITING
-
Retinoblastoma Phase II Expanded Access Clinical Trial
RECRUITING · Phase 2
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.